Ryan D Maynard is Director of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 7,500 shares of IOVA, which is worth approximately $61,050. The most recent transaction as insider was on Nov 12, 2024, when has been sold 50,000 shares (Common Stock) at a price of $10.06 per share, resulting in proceeds of $503,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.5K
0% 3M change
0% 12M change
Total Value Held $61,050

Ryan D Maynard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 12 2024
SELL
Open market or private sale
$503,000 $10.06 p/Share
50,000 Reduced 86.96%
7,500 Common Stock
Nov 12 2024
BUY
Exercise of conversion of derivative security
$372,500 $7.45 p/Share
50,000 Added 46.51%
57,500 Common Stock
May 31 2022
BUY
Open market or private purchase
$50,625 $6.75 p/Share
7,500 Added 50.0%
7,500 Common Stock

Also insider at

CARA
Cara Therapeutics, Inc. Healthcare
RDM

Ryan D Maynard

Director
Stamford, CT

Track Institutional and Insider Activities on IOVA

Follow IOVANCE BIOTHERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA